Literature DB >> 16623018

Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.

Suchat Suppapitiporn1, Busba Chindavijak, Saowapa Onsanit.   

Abstract

BACKGROUND: type 2 diabetes mellitus continues to increase in prevalence worldwide. Many factors have been cited as contributing to compliance, such as family and social support, education, number of tablets per dose, frequency of administration and health care provider communication. Toward these goals, the present study was developed to measure the effect offactors on glycemic control such as diabetes education by pharmacists, a diabetes disease booklet and special medication containers. MATERIAL AND
METHOD: A total of 360 volunteers with type 2 DM patients were recruited, participants were simple randomized to control 180 and intervention 180 patients. Which intervention categorized to 4 groups; all intervention groups received diabetes drug counseling by a pharmacist, one group received plus a diabetes booklet, one received plus special medical containers and the last group received all of them. The interventions were done at the 1st time of visit. Both the control and intervention groups were monitored for fasting plasma glucose and HbA1c at 0, 3, 6 months and glycemic level in both groups was compared.
RESULTS: After 3 months, mean fasting plasma glucose and HbA1c decreased wiih the intervention group vs. control group (152.36 +/- 39.73 to 131.52 +/- 35.22 mg%) and (150.16 +/- 41.78 to 153.98 +/- 47.95 mg%) respectively; (p < 0.001). HbA1c level 8.16 +/- 1.44 to 7.72 +/- 1.26 vs 8.01 +/- 1.51 to 8.38 +/- 1.46 respectively; (p < 0.001). After 6 months, mean fasting plasma glucose and HbA1c decreased with the intervention group vs. control group (152.36 +/- 39.73 to 145.20 +/- 46.07 mg%) and (150.16 +/- 41.78 to 159.16 +/- 54.90 mg%) respectively; (p < 0.013). HbA1c level 8.16 +/- 1.44 to 7.91 +/- 1.27 vs. 8.01 +/- 1.51 to 8.80 +/- 1.36 respectively; (p < 0.001). The most favorable glycemic outcome was the group that received all of the interventions; mean FPG was reduced from 147.46 +/- 36.07 to 125.38 +/- 31.12 mg% (p < 0.000) in 1nd visit (3 months later) and still reducing effect on the 2nd visit (6 month later) mean FPG from 147.46 +/- 36.07 to 130.21 +/- 33.96 mg% (p < 0.016) also the same way in HbA 1c level. The group that received only drug counseling by pharmacist had no significant reduction in FPG and HbA1c. (p > 0.05).
CONCLUSION: Drug counseling by a pharmacist has little beneficial effect on diabetes management outcome compared to the diabetes booklet and special drug container. To improve glycemic control of type 2 DM is to integrate self-management in daily life, wide a variety of education, drug taken behavior and health care provider available communication produce improvement in patient management and is somewhat better when used in combination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16623018

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  20 in total

1.  Evidence based review of type 2 diabetes prevention and management in low and middle income countries.

Authors:  Aimee Afable; Nidhi Shree Karingula
Journal:  World J Diabetes       Date:  2016-05-25

2.  Evaluation of T2DM related knowledge and practices of Omani patients.

Authors:  Zeyana S Al Bimani; Shah Alam Khan; Pratap David
Journal:  Saudi Pharm J       Date:  2013-12-22       Impact factor: 4.330

Review 3.  Interventions for enhancing medication adherence.

Authors:  Robby Nieuwlaat; Nancy Wilczynski; Tamara Navarro; Nicholas Hobson; Rebecca Jeffery; Arun Keepanasseril; Thomas Agoritsas; Niraj Mistry; Alfonso Iorio; Susan Jack; Bhairavi Sivaramalingam; Emma Iserman; Reem A Mustafa; Dawn Jedraszewski; Chris Cotoi; R Brian Haynes
Journal:  Cochrane Database Syst Rev       Date:  2014-11-20

4.  Improvement of diabetes indices of care by a short pharmaceutical care program.

Authors:  Mertkan Turnacilar; Mesut Sancar; Sule Apikoglu-Rabus; Mehmet Hursitoglu; Fikret Vehbi Izzettin
Journal:  Pharm World Sci       Date:  2009-09-24

5.  Diabetes care in Norwegian pharmacies: a descriptive study.

Authors:  Reidun L S Kjome; Sverre Sandberg; Anne Gerd Granås
Journal:  Pharm World Sci       Date:  2007-09-22

Review 6.  Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review.

Authors:  Lucas Miyake Okumura; Inajara Rotta; Cassyano Januário Correr
Journal:  Int J Clin Pharm       Date:  2014-07-23

Review 7.  Written information about individual medicines for consumers.

Authors:  Donald Nicolson; Peter Knapp; D K Theo Raynor; Pat Spoor
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

8.  Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.

Authors:  Nadia Rashid Al Mazroui; Mostafa Mohamed Kamal; Naserdeen Mehana Ghabash; Targ Ahmed Yacout; Prashant Laxman Kole; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2009-02-11       Impact factor: 4.335

9.  Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial.

Authors:  Shadi Farsaei; Ali Mohammad Sabzghabaee; Amir Hooshang Zargarzadeh; Massoud Amini
Journal:  J Res Med Sci       Date:  2011-01       Impact factor: 1.852

10.  Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.

Authors:  Liz Steed; Ratna Sohanpal; Adam Todd; Vichithranie W Madurasinghe; Carol Rivas; Elizabeth A Edwards; Carolyn D Summerbell; Stephanie Jc Taylor; R T Walton
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.